MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Phase 4

Completed

Conditions: Barrett's Esophagus
Obesity

Interventions: Drug: Placebo
Drug: Omega-3 polyunsaturated fatty acids

First Posted Date: 2012-11-26

Last Posted Date: 2022-01-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT01733147

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

Phase 2

Completed

Conditions: Anemia
Primary Myelofibrosis
Secondary Myelofibrosis

Interventions: Drug: ruxolitinib phosphate
Drug: danazol
Other: quality-of-life assessment
Other: questionnaire administration

First Posted Date: 2012-11-22

Last Posted Date: 2017-10-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 14

Registration Number: NCT01732445

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Tisch Cancer Center, New York, New York, United States

Dietary Interventions in Prediabetes

Not Applicable

Completed

Conditions: Liver Fat
Impaired Fasting Glucose
Pre Diabetes

Interventions: Dietary Supplement: Dietary intervention

First Posted Date: 2012-11-20

Last Posted Date: 2015-07-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT01729078

Locations: 🇺🇸
Mayo clinic, Rochester, Minnesota, United States

A Study to Assess the Efficacy of Early Physical Therapy Intervention Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer

Not Applicable

Completed

Conditions: Shoulder Weakness Following Neck Dissection Surgery

Interventions: Other: Physical therapy intervention

First Posted Date: 2012-11-20

Last Posted Date: 2015-05-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01729065

Locations: 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States

Vestibular Function Outcome After Cartilage Cap Occlusion Surgery

Early Phase 1

Withdrawn

Conditions: Vestibular Dizziness
Superior Semicircular Canal Dehiscence

Interventions: Procedure: cartilage cap occlusion surgery

First Posted Date: 2012-11-16

Last Posted Date: 2014-02-12

Lead Sponsor: Mayo Clinic

Registration Number: NCT01727544

MR-Guided Cryoablation of Prostate Bed Recurrences

Not Applicable

Recruiting

Conditions: Prostate Tumors

Interventions: Procedure: MR-guided cryoablation

First Posted Date: 2012-11-15

Last Posted Date: 2024-01-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 200

Registration Number: NCT01727284

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

Completed

Conditions: Obesity
Diabetes Mellitus Type 2 in Obese

First Posted Date: 2012-11-15

Last Posted Date: 2018-01-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 46

Registration Number: NCT01726491

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Mitochondrial Dysfunction in Diabetes

Not Applicable

Completed

Conditions: Obese
Diabetes

Interventions: Behavioral: Exercise and muscle biopsies

First Posted Date: 2012-11-09

Last Posted Date: 2014-05-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 16

Registration Number: NCT01724502

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

PGC-1 and Mitochondrial Dysfunction in Diabetes

Not Applicable

Completed

Conditions: Diabetes
Obese

Interventions: Other: Lipid infusion and muscle biopsies

First Posted Date: 2012-11-09

Last Posted Date: 2014-05-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 16

Registration Number: NCT01724515

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

Phase 1

Completed

Conditions: Logopenic Variant of Primary Progressive Aphasia (LPA)
Atypical Alzheimers Disease
Posterior Cortical Atrophy (PCA)

Interventions: Drug: C-11 PiB

First Posted Date: 2012-11-08

Last Posted Date: 2015-12-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 27

Registration Number: NCT01723553

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy